{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-040955","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.259517+00:00","generated_at":"2026-06-02T07:16:06.138438+00:00","sec_items":["5.08","3.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cadrenal Therapeutics sets 2024 Annual Meeting for July 29, 2024; updates stockholder proposal deadlines","bullets":["Annual Meeting scheduled for July 29, 2024; record date set as June 6, 2024.","Stockholder proposals under Rule 14a-8 must be received by May 20, 2024.","Director nominations and other proposals not included in proxy also due by May 20, 2024.","Universal proxy rule compliance notice due by May 30, 2024 (60 days before meeting)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-040955","json":"https://secwatch.observer/filing/0001213900-24-040955.json","markdown":"https://secwatch.observer/filing/0001213900-24-040955.md","text":"https://secwatch.observer/filing/0001213900-24-040955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390024040955/0001213900-24-040955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390024040955/ea020556601-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T07:16:06.138438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}